The Independence
(L to R) Drs. Shaf Keshavjee and Michael Laflamme. (Photo: UHN)

Two UHN researchers have won awards from Medicine by Design at the University of Toronto.

Dr. Shaf Keshavjee, UHN's Surgeon-in-Chief, and Dr. Michael Laflamme, a senior scientist at the Toronto General Research Institute and the McEwen Centre for Regenerative Medicine at UHN, will share more than $400,000 to help take their projects from the laboratory bench to the bedside after being named winners of the Medicine by Design Clinical Translation and Commercialization Awards earlier today.

Dr. Keshavjee, also a professor of thoracic surgery at U of T, won the award for his team's work on ex vivo lung perfusion, or EVLP, a technology enabling better assessment and support of donated lungs.

Dr. Laflamme, also an associate professor in U of T's Department of Laboratory Medicine and Pathobiology, will use his award to advance his pioneering technique to treat heart failure.

For full details of the awards, click here.

Share This Story

Share Tweet Email